DARPA Profiles Singletto’s Oxafence® Moving from PPB Research to Military Medical Evaluations and Commercial Expansion

DARPA profiles Singletto’s transition from DARPA’s Personalized Protective Biosystems program to the Embedded Entrepreneur Initiative, tracing the Oxafence® Active Protection technology’s move from research into military medical evaluations and expanding commercial use.

SSingletto